On 16 December, the DHSC announced that the 2025 headline VPAG repayment percentage for sales of “newer medicines” will be 22.9%. This...

In London last week, over 400 attendees and speakers gathered together for the fifth annual SynbiTECH conference in London. The event...

The Terminally Ill Adults (End of Life) Bill, introduced as a private members’ bill by Kim Leadbeater MP on 11 November 2024 (Leadbeater...

The consultation on the future of the UK’s Medical Devices Regulations 2002 (UK MDR), initiated by the MHRA on 14 November 2024,...

Background The MHRA has launched a Consultation on future changes to the UK Medical Devices Regulations. The consultation addresses four...

As briefly mentioned in our article last week on Priority Review Vouchers, the financial terms of a biopharma patent licence agreement...

We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...

On 5 November 2024, Acadia Pharmaceuticals Inc. ("Acadia") announced that it sold its rare paediatric disease priority review voucher...

The MHRA has provided more information on its plans for rolling-out its new medical device framework. It aims to publish its additional...

Last week, the European Parliament (EP) passed a resolution calling on the European Commission (EC) to further revise the Medica Devices...

On 25 September 2024, the MHRA updated its roll-out of the new medical device regulatory framework for Great Britain. The MHRA aims to...

TEAM-NB has published a new version (v5.0) of its Code of Conduct for Notified Bodies. While we don’t normally comment on this Code,...